Antisoma Plc Acquires Xanthus Pharmaceuticals, Inc. for $52,200,000

  • Feed Type
  • Date
    5/16/2008
  • Company Name
    Xanthus Pharmaceuticals, Inc.
  • Mailing Address
    300 Technology Square Cambridge, MA 02139
  • Company Description
    Xanthus is a biopharmaceutical company focused on the discovery, development, acquisition and commercialization of small-molecule therapeutics for the treatment of cancer and autoimmune disorders.
  • Website
    http://www.xanthus.com
  • Transaction Type
    M&A
  • Transaction Amount
    $52,200,000
  • Transaction Round
  • Proceeds Purposes
  • M&A Terms
    The acquisition will be paid for with Antisoma shares.

By posting a comment, you agree to our terms and conditions.